Novavax Inc (NVAX)
3.895
0.00 (0.00%)
USD |
NASDAQ |
Apr 18, 16:00
3.89
0.00 (0.00%)
Pre-Market: 08:47
Novavax Cash and Short Term Investments (Quarterly): 568.50M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 568.50M |
September 30, 2023 | 651.10M |
June 30, 2023 | 505.91M |
March 31, 2023 | 624.95M |
December 31, 2022 | 1.337B |
September 30, 2022 | 1.281B |
June 30, 2022 | 1.376B |
March 31, 2022 | 1.571B |
December 31, 2021 | 1.515B |
September 30, 2021 | 1.937B |
June 30, 2021 | 2.075B |
March 31, 2021 | 1.998B |
December 31, 2020 | 711.05M |
September 30, 2020 | 504.03M |
June 30, 2020 | 502.30M |
March 31, 2020 | 237.36M |
December 31, 2019 | 78.82M |
September 30, 2019 | 71.17M |
June 30, 2019 | 72.00M |
March 31, 2019 | 100.20M |
December 31, 2018 | 92.13M |
September 30, 2018 | 127.11M |
June 30, 2018 | 167.11M |
March 31, 2018 | 143.76M |
December 31, 2017 | 157.30M |
Date | Value |
---|---|
September 30, 2017 | 172.57M |
June 30, 2017 | 187.31M |
March 31, 2017 | 211.18M |
December 31, 2016 | 235.48M |
September 30, 2016 | 300.28M |
June 30, 2016 | 366.36M |
March 31, 2016 | 433.87M |
December 31, 2015 | 230.66M |
September 30, 2015 | 290.19M |
June 30, 2015 | 314.94M |
March 31, 2015 | 327.74M |
December 31, 2014 | 168.06M |
September 30, 2014 | 178.09M |
June 30, 2014 | 152.46M |
March 31, 2014 | 112.83M |
December 31, 2013 | 133.07M |
September 30, 2013 | 146.41M |
June 30, 2013 | 40.60M |
March 31, 2013 | 44.28M |
December 31, 2012 | 44.11M |
September 30, 2012 | 28.41M |
June 30, 2012 | 26.54M |
March 31, 2012 | 20.72M |
December 31, 2011 | 18.31M |
September 30, 2011 | 19.60M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
71.17M
Minimum
Sep 2019
2.075B
Maximum
Jun 2021
927.15M
Average
651.10M
Median
Sep 2023
Cash and Short Term Investments (Quarterly) Benchmarks
Pfizer Inc | 12.69B |
Moderna Inc | 8.604B |
Agilent Technologies Inc | 1.748B |
Align Technology Inc | 972.74M |
Lexicon Pharmaceuticals Inc | 170.03M |